AEON Biopharma, Inc. (AEON) Executive Compensation
AEON Biopharma, Inc. (AEON) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AEON
CIK: 1837607
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerEdward Bryant
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| PRE 14A | 2026-10-13 | 2026-10-13 | PRE 14A | 0001837607-26-000068 | View SEC Doc Filr Page |
| 8-K | 2026-09-30 | 2026-09-30 | 8-K | 0001837607-26-000064 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-21 | — | SCHEDULE 13G Filing | 0000935836-26-000442 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | FORM 4 | 0000935836-26-000440 | View SEC Doc Filr Page |
| 3 | 2026-08-21 | 2026-08-19 | FORM 3 | 0000935836-26-000438 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001837607-26-000062 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001837607-26-000061 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001837607-26-000057 | View SEC Doc Filr Page |
| 8-K | 2026-07-23 | 2026-07-23 | 8-K | 0001837607-26-000055 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-21 | — | SCHEDULE 13G Filing | 0001440771-26-000012 | View SEC Doc Filr Page |
| 8-K | 2026-07-15 | 2026-07-13 | 8-K | 0001837607-26-000052 | View SEC Doc Filr Page |
| 424B4 | 2026-07-15 | — | 424B4 | 0001104659-26-083680 | View SEC Doc Filr Page |
| EFFECT | 2026-07-13 | — | EFFECT Filing | 9999999995-26-002285 | View SEC Doc Filr Page |
| S-1MEF | 2026-07-13 | — | S-1MEF | 0001104659-26-083252 | View SEC Doc Filr Page |
| S-1/A | 2026-07-09 | — | S-1/A | 0001104659-26-082167 | View SEC Doc Filr Page |
| S-1 | 2026-07-08 | — | S-1 | 0001104659-26-081860 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | OWNERSHIP DOCUMENT | 0001104659-26-076515 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | OWNERSHIP DOCUMENT | 0001104659-26-076513 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | OWNERSHIP DOCUMENT | 0001104659-26-076511 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | OWNERSHIP DOCUMENT | 0001104659-26-076510 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | OWNERSHIP DOCUMENT | 0001104659-26-076509 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-17 | 8-K | 0001837607-26-000046 | View SEC Doc Filr Page |
| DRS | 2026-05-29 | — | DRS Filing | 0001104659-26-068203 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001837607-26-000043 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001837607-26-000042 | View SEC Doc Filr Page |